THE CORPORATE LIBRARY

Related Party Transactions and Outside Related Director Information

Cryolife, Inc. (CRY)

4/4/2006 Proxy Information

CryoLife employs Mr. Anderson's son, Bruce G. Anderson, age 39, as Director of Cardiovascular Field Services in the Marketing Department. He has held various positions within the Company since 1994. His compensation during 2005, including commissions, was $199,791.

In 2003, Mr. Benson was engaged by the law firm representing a Special Litigation Committee of the Board of Directors of the Company to serve as an expert witness to the Special Litigation Committee's independent investigation into allegations made by the Plaintiffs in the shareholder derivative lawsuit filed against the Company's Directors, which was settled in 2005. Mr. Benson billed that law firm a total of approximately $52,500 for services provided in 2003. Mr. Benson was engaged to serve as an expert witness by a different law firm representing the Company in the securities class action shareholder lawsuit filed against the Company, which was also settled in 2005. Mr. Benson billed a total of approximately $38,000 in expert witness fees for services provided in 2004 (approximately $28,500) and 2005 (approximately $9,500). The Nominating and Corporate Governance Committee and the Board of Directors were informed of these engagements at the time he was appointed as a Director, and concluded that he was independent. The basis for this determination was that Mr. Benson's relationship was indirect and has ended, and that Mr. Benson had been interviewed and subsequently approved as a candidate for the Board of Directors by plaintiffs' counsel in the derivative lawsuit.

12/28/2005 8K Information

In 2003, Mr. Benson was engaged by the law firm representing the Special Litigation Committee of the Board of Directors of the Company to serve as an expert witness in the shareholder derivative lawsuit filed against the Company's Directors, which was settled in August 2005. Mr. Benson invoiced that law firm a total of approximately $52,500 for services provided in 2003. M4/28/2005r. Benson was engaged to serve as an expert witness by a different law firm representing the Company in the securities class action shareholder lawsuit filed against the Company. Mr. Benson invoiced a total of approximately $38,000 in expert witness fees for services provided in 2004 (approximately $28,500) and 2005 (approximately $9,500). As disclosed in the Company's Current Report on Form 8-K filed on December 12, 2005, that lawsuit was settled in December 2005.

4/28/2005 Proxy Information

CryoLife employs Mr. Anderson's son, Bruce G. Anderson, 38, as Director of Cardiovascular Field Services in the Marketing Department. He has held various positions within the Company since 1994. His compensation during 2004, including commissions, was $215,414.

4/29/2004 Proxy Information

CryoLife employs Mr. AndersonÕs son, Bruce G. Anderson, 38, as Director of Cardiovascular Field Services in the Marketing Department. He has held various positions within the Company since 1994. His compensation during 2003, including commissions, was $212,651.

Massachusetts Financial Services Company, a registered investment adviser, is the beneficial owner of more than five percent of CryoLifeÕs outstanding shares due to its discretionary voting and dispositive control over those shares, which are owned of record by several trusts. In January 2004 the trusts acquired 190,000 shares of CryoLifeÕs common stock in a private placement for an aggregate purchase price of $1,187,500.

In addition to the foregoing, Mr. McCall received approximately $96,730 in legal fees, excluding reimbursement for expenses of $3,859, from CryoLife in 2003.

4/29/2003 Proxy Information

Dr. Elkins received approximately $100,000 in consulting fees in 2002, Dr. Van Dyne received approximately $7,500 in consulting fees in 2002 and Mr. McCall received approximately $89,820 in legal fees, including reimbursement for expenses, from CryoLife in 2002. The paid consulting arrangements between Drs. Elkins and Van Dyne and CryoLife terminated in 2002.